Application of Metabolomics to Identify Potential Biomarkers for the Early Diagnosis of Coronary Heart Disease
Coronary heart disease (CHD) is one of the leading causes of deaths globally. Identification of serum metabolic biomarkers for its early diagnosis is thus much desirable. Serum samples were collected from healthy controls (n = 86) and patients with CHD (n = 166) and subjected to untargeted and targe...
Guardado en:
Autores principales: | Huali Jiang, Li Li, Weijie Chen, Benfa Chen, Heng Li, Shanhua Wang, Min Wang, Yi Luo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2698c3f75aec449dac39bec9c131e4b7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Metabolomic Characterization of Fatty Acids in Patients With Coronary Artery Ectasias
por: Tianlong Liu, et al.
Publicado: (2021) -
In situ Metabolomics of Metabolic Reprogramming Involved in a Mouse Model of Type 2 Diabetic Kidney Disease
por: Bai Linnan, et al.
Publicado: (2021) -
Can Diet Influence Our Health by Altering Intestinal Microbiota-Derived Fecal Metabolites?
por: Qiang Lyu, et al.
Publicado: (2018) -
Alterations in Gut Glutamate Metabolism Associated with Changes in Gut Microbiota Composition in Children with Autism Spectrum Disorder
por: Mingbang Wang, et al.
Publicado: (2019) -
Sustainable Hues: Exploring the Molecular Palette of Biowaste Dyes through LC-MS Metabolomics
por: Ralph John Emerson J. Molino, et al.
Publicado: (2021)